These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2192852)

  • 41. Treatment of type II diabetes: what options have been added to traditional methods?
    Cefalu WT
    Postgrad Med; 1996 Mar; 99(3):109-19, 122. PubMed ID: 8637824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral combination therapy with thiazolidinediones and sulfonylureas in type 2 diabetes.
    Charbonnel B
    Int J Clin Pract Suppl; 2007 Jun; (153):1-2. PubMed ID: 17594387
    [No Abstract]   [Full Text] [Related]  

  • 43. Acarbose: its role in the treatment of diabetes mellitus.
    Campbell LK; White JR; Campbell RK
    Ann Pharmacother; 1996 Nov; 30(11):1255-62. PubMed ID: 8913408
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Possibilities and limits of oral diabetes therapy].
    Bruneder H
    Wien Med Wochenschr; 1985 Apr; 135(6-7):147-51. PubMed ID: 3890376
    [No Abstract]   [Full Text] [Related]  

  • 45. Comparative Impact of Hypoglycemic Agents on Severity and Extent of Myocardial Ischemia in Patients With Type 2 Diabetes Mellitus Undergoing Myocardial Perfusion Scintigraphy.
    Biondi-Zoccai G; Pinto A; Versaci F; Procaccini E; Neri G; Sesti G; Uccioli L; Vetere M; Peruzzi M; Nudi F
    J Cardiovasc Pharmacol; 2016 Aug; 68(2):162-70. PubMed ID: 27074768
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combined insulin-sulfonylurea treatment of type II diabetes.
    Bingham PR; Riddle MC
    Diabetes Educ; 1989; 15(5):450-5. PubMed ID: 2673707
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined insulin-sulfonylurea therapy in treatment of NIDDM.
    Groop LC; Groop PH; Stenman S
    Diabetes Care; 1990 Aug; 13 Suppl 3():47-52. PubMed ID: 2209344
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Does insulin preserve beta-cell function in type 2 diabetes?
    Heise T; Sawicki PT
    J Intern Med; 2002 Apr; 251(4):283-5. PubMed ID: 11952878
    [No Abstract]   [Full Text] [Related]  

  • 49. The 32nd annual meeting of the European Association for the Study of Diabetes. Leptin, insulin resistance, intrauterine malnutrition, sulfonylureas, oral agents alone and with insulin, and new pharmacological approaches to type 2 diabetes.
    Bloomgarden ZT
    Diabetes Care; 1997 Aug; 20(8):1334-7. PubMed ID: 9250465
    [No Abstract]   [Full Text] [Related]  

  • 50. Management of non-insulin-dependent diabetes mellitus.
    Williams G
    Lancet; 1994 Jan; 343(8889):95-100. PubMed ID: 7903785
    [No Abstract]   [Full Text] [Related]  

  • 51. Combined insulin and oral sulfonylureas--how sweet it isn't!
    Ponte CD
    DICP; 1990 Dec; 24(12):1234-5. PubMed ID: 2089839
    [No Abstract]   [Full Text] [Related]  

  • 52. Do sulfonylureas influence hepatic insulin clearance?
    Groop LC; Groop PH; Stenman S; Saloranta C; Tötterman KJ; Fyhrquist F; Melander A
    Diabetes Care; 1988 Sep; 11(8):689-90. PubMed ID: 3065007
    [No Abstract]   [Full Text] [Related]  

  • 53. Clinical utility of oral hypoglycemic agents in the management of patients with noninsulin-dependent diabetes mellitus.
    Lebovitz HE
    Am J Med; 1983 Nov; 75(5B):94-9. PubMed ID: 6369972
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A 12-h intravenous insulin infusion restores the beta-cell response torpidity to sulfonylureas in patients affected by type 2 diabetes.
    Sinagra D; Greco D; Amato MC; D'Acquisto G; Galluzzo A
    Diabetes Care; 2000 Dec; 23(12):1857-8. PubMed ID: 11128371
    [No Abstract]   [Full Text] [Related]  

  • 55. Oral antihyperglycemic therapy for type 2 diabetes: clinical applications.
    Holmboe ES
    JAMA; 2002 Jan; 287(3):373-6. PubMed ID: 11790217
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combination sulfonylurea and insulin therapy in non-insulin-dependent diabetes mellitus.
    Collo MB; Johnson JL; Kabadi UM
    Nurse Pract; 1993 Jul; 18(7):40, 43-4, 47-8. PubMed ID: 8351085
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Determining the most appropriate treatment for patients with non-insulin-dependent diabetes mellitus.
    Cooppan R
    Metabolism; 1987 Feb; 36(2 Suppl 1):17-21. PubMed ID: 3543617
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Type 2 diabetes: treat to target.
    Funnell MM; Kruger DF
    Nurse Pract; 2004 Jan; 29(1):11-5, 19-23; quiz 23-5. PubMed ID: 14726786
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Treatment of diabetes mellitus in the elderly].
    Oba K
    Nihon Ronen Igakkai Zasshi; 2005 Sep; 42(5):512-5. PubMed ID: 16248409
    [No Abstract]   [Full Text] [Related]  

  • 60. [Lights and shades in the application of new guidelines for the management of type 2 diabetes mellitus. Practical advice about combined therapy and insulin therapy].
    Sánchez Sánchez O; Sabán Ruiz J
    Med Clin (Barc); 2008 Feb; 130(5):188-96. PubMed ID: 18341835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.